4//SEC Filing
BIO-TECHNE Corp 4
Accession 0000842023-15-000002
$TECHCIK 0000842023operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 1:38 PM ET
Size
20.3 KB
Accession
0000842023-15-000002
Insider Transaction Report
Form 4
BIO-TECHNE Corptech
OCONNELL HOWARD V
Director
Transactions
- Exercise/Conversion
Common Stock
2015-02-19$56.17/sh+5,000$280,850→ 75,000 total(indirect: By Trust) - Sale
Common Stock
2015-02-19$95.78/sh−5,000$478,882→ 70,000 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2015-02-19−5,000→ 0 total(indirect: By Trust)Exercise: $56.17From: 2006-10-26Exp: 2016-10-25→ Common Stock (5,000 underlying)
Holdings
- 2,000
Common Stock
- 4,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 4,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 5,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $66.90From: 2012-10-25Exp: 2022-10-24→ Common Stock (5,000 underlying) - 5,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $70.35From: 2011-10-27Exp: 2021-10-26→ Common Stock (5,000 underlying) - 5,000(indirect: By Trust)
Stock Option
Exercise: $61.46From: 2010-10-28Exp: 2020-10-27→ Common Stock (5,000 underlying) - 5,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $63.03From: 2009-10-29Exp: 2019-10-28→ Common Stock (5,000 underlying) - 5,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $65.47From: 2008-10-23Exp: 2018-10-22→ Common Stock (5,000 underlying) - 5,000(indirect: By Trust)
Stock Option (right to buy)
Exercise: $66.59From: 2007-10-25Exp: 2017-10-24→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.75 to $95.91 inclusive. The reporting person undertakes to provide Bio-Techne Corp., any security holder of Bio-Techne Corp. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0000842023
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 1:38 PM ET
- Size
- 20.3 KB